Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Sorafenib can cause a unique skin reaction.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Selaginella doederleinii extract shows potential for cervical cancer treatment but needs more research.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

New treatments targeting genetic mutations in lung cancer are needed for better outcomes.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.